Asymmetrical Dimethylarginine: The Über Marker?

Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease

Schächinger, V., Britten, M. B., & Zeiher, A. M. (2000) · Circulation · doi:10.1161/01.cir.101.16.1899 · Cited by 2,589

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107

Long-Term Follow-Up of Patients With Mild Coronary Artery Disease and Endothelial Dysfunction

Suwaidi, J. M. S. A., Hamasaki, S., Higano, S. T., Nishimura, R. A., Holmes, D. R., & Lerman, A. (2000) · Circulation · doi:10.1161/01.cir.101.9.948 · Cited by 2,044

Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors

Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia

Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L. S., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07217-8 · Cited by 1,087

Predictive value of noninvasivelydetermined endothelial dysfunction for long-term cardiovascular events inpatients with peripheral vascular disease

Gokce, N., Keaney, J. F., Hunter, L. M., Watkins, M. T., Nedeljkovic, Z. S., Menzoı́an, J. O., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00333-4 · Cited by 776

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene.

von der Leyen, H. E., Gibbons, G. H., Morishita, R., Lewis, N. P., Zhang, L., Nakajima, M., Kaneda, Y., Cooke, J. P., & Dzau, V. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1137 · Cited by 763

Endogenous Nitric Oxide Synthase Inhibitor

Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756

NITRIC OXIDE SYNTHASE: Role in the Genesis of Vascular Disease

Cooke, J. P., & Dzau, V. J. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.489 · Cited by 706

Superoxide Generation from Endothelial Nitric-oxide Synthase

Xia, Y., Tsai, A.-L., Berka, V., & Zweier, J. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25804 · Cited by 705

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

Cooke, J. P., Singer, A. H., Tsao, P. S., Zera, P. H., Rowan, R. A., & Billingham, M. E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115937 · Cited by 683

Homocysteine Impairs the Nitric Oxide Synthase Pathway

Stuehlinger, M., Tsao, P. S., Her, J. H., Kimoto, M., Balint, R. F., & Cooke, J. P. (2001) · Circulation · doi:10.1161/hc4601.098514 · Cited by 662

Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus

Lin, K. Y., Ito, A., Asagami, T., Tsao, P. S., Adimoolam, S., Kimoto, M., Tsuji, H., Reaven, G. M., & Cooke, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000027109.14149.67 · Cited by 651

Novel Mechanism for Endothelial Dysfunction

Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T., & Cooke, J. P. (1999) · Circulation · doi:10.1161/01.cir.99.24.3092 · Cited by 629

Accelerated Atherosclerosis, Aortic Aneurysm Formation, and Ischemic Heart Disease in Apolipoprotein E/Endothelial Nitric Oxide Synthase Double-Knockout Mice

Kuhlencordt, P., Gyurko, R., Han, F., Scherrer‐Crosbie, M., Aretz, T. H., Hajjar, R. J., Picard, M. H., & Huang, P. L. (2001) · Circulation · doi:10.1161/hc2901.091399 · Cited by 628

Asymmetric Dimethylarginine Causes Hypertension and Cardiac Dysfunction in Humans and Is Actively Metabolized by Dimethylarginine Dimethylaminohydrolase

Achan, V., Broadhead, M., Malaki, M., Whitley, G. S. J., LEIPER, J. M., MacAllister, R. J., & Vallance, P. J. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593

Relationship Between Insulin Resistance and an Endogenous Nitric Oxide Synthase Inhibitor

Stuehlinger, M. (2002) · JAMA · doi:10.1001/jama.287.11.1420 · Cited by 578

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

Valkonen, V.-P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimäki, T., Laakso, J., & Laaksonen, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07184-7 · Cited by 562

Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase

Liao, J. K., Shin, W. S., Lee, W. Y., & Clark, S. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.319 · Cited by 543

Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia

Savvidou, M. D., Hingorani, A. D., Tsikas, D., Frölich, J. C., Vallance, P. J., & Nicolaides, K. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13177-7 · Cited by 515

Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease

Böger, R. H., Bode‐Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

LEIPER, J. M., MARIA, J. S., Chubb, A., MacAllister, R. J., Charles, I. G., Whitley, G. S. J., & Vallance, P. J. (1999) · Biochemical Journal · doi:10.1042/bj3430209 · Cited by 478

LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells

Böger, R. H., Sydow, K., Borlak, J. T., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., & Bode‐Böger, S. M. (2000) · Circulation Research · doi:10.1161/01.res.87.2.99 · Cited by 478

ADMA and oxidative stress

Sydow, K., & Münzel, T. F. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00033-3 · Cited by 433

A Caveolar Complex between the Cationic Amino Acid Transporter 1 and Endothelial Nitric-oxide Synthase May Explain the “Arginine Paradox”

McDonald, K., Zharikov, S. I., Block, E. R., & Kilberg, M. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31213 · Cited by 432

Reduced Urinary Excretion of Nitric Oxide Metabolites and Increased Plasma Levels of Asymmetric Dimethylarginine in Men with Essential Hypertension

Surdacki, A., Nowicki, M. P., Sandmann, J., Tsikas, D., Boeger, R. H., Bode-Boeger, S. M., Kruszelnicka-Kwiatkowska, O., Kokot, F., Dubiel, J. S., & Froelich, J. C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199904000-00020 · Cited by 422

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

MacAllister, R. J., Parry, H., Kimoto, M., Ogawa, T., Russell, R. J., Hodson, H. F., Whitley, G. S. J., & Vallance, P. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16069.x · Cited by 394

Gene therapy inhibiting neointimal vascular lesion

Leyen, V. D. (1995) · Medical Entomology and Zoology · Cited by 386

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

Abbasi, F., Asagmi, T., Cooke, J. P., Lamendola, C. A., McLaughlin, T., Reaven, G. M., Stuehlinger, M., & Tsao, P. S. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02063-x · Cited by 357

Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis

Dayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stuehlinger, M. C., Wang, B., Tsao, P. S., Kimoto, M., Vallance, P. J., Patterson, A. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101924.04515.2e · Cited by 340

Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.

Tsao, P. S., McEvoy, L. M., Drexler, H., Butcher, E. C., & Cooke, J. P. (1994) · Circulation · doi:10.1161/01.cir.89.5.2176 · Cited by 324

Association of the Missense Glu298Asp Variant of the Endothelial Nitric Oxide Synthase Gene With Myocardial Infarction

Shimasaki, Y., Yasue, H., Yoshimura, M., Nakayama, M., Kugiyama, K., Ogawa, H., Harada, E., Masuda, T., Koyama, W., Saito, Y., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00167-3 · Cited by 316

The DDAH/ADMA/NOS pathway

Tran, C. T. L., LEIPER, J. M., & Vallance, P. J. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00032-1 · Cited by 315

Asymmetric Dimethylarginine, C-Reactive Protein, and Carotid Intima-Media Thickness in End-Stage Renal Disease

Zoccali, C., Benedetto, F. A., Maas, R., Mallamaci, F., Tripepi, G. L., Malatino, L., & Diaeresis]ger, R. B. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132490 · Cited by 315

Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia

Stuehlinger, M., Oka, R. K., Graf, E. E., Schmoelzer, I., Upson, B. M., Kapoor, O., Szuba, A., Malinow, M. R., Wascher, T. C., Pachinger, O. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000085067.55901.89 · Cited by 303

Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction

嶋崎, 幸. (1999) · Medical Entomology and Zoology · doi:10.11501/3166056 · Cited by 292

S -nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: Further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

LEIPER, J. M., Murray‐Rust, J., McDonald, N. Q., & Vallance, P. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212269799 · Cited by 288

NO and angiogenesis

Cooke, J. P. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00034-5 · Cited by 266

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

Böger, R. H., Bode‐Böger, S. M., Thiele, W., Creutzig, A., Alexander, K., & Frölich, J. C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00375-1 · Cited by 263

Antioxidant Vitamins C and E Improve Endothelial Function in Children With Hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial

Engler, M. M., Engler, M. B., Malloy, M. J., Chiu, E. Y., Schloetter, M. C., Paul, S. M., Stuehlinger, M., Lin, K. Y., Cooke, J. P., Morrow, J. D., et al. (2003) · Circulation · doi:10.1161/01.cir.0000086345.09861.a0 · Cited by 253

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality

Nijveldt, R. J. (2003) · Clinical Nutrition · doi:10.1054/clnu.2002.0613 · Cited by 252

Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension: Modulation of Nitric Oxide Synthesis by Salt Intake

Fujiwara, N., Osanai, T., Kamada, T., Katoh, T., Takahashi, K., & Okumura, K. (2000) · Circulation · doi:10.1161/01.cir.101.8.856 · Cited by 242

Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine

Lundman, P., Eriksson, M. J., Stuehlinger, M., Cooke, J. P., Hamsten, A., & Tornvall, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01318-3 · Cited by 236

Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure

Usui, M., Matsuoka, H., Miyazaki, H., Ueda, S., Okuda, S., & Imaizumi, T. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00225-2 · Cited by 232

An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes

Böger, R. H., Bode‐Böger, S. M., Tsao, P. S., Lin, P. S., Chan, J. R., & Cooke, J. P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01013-5 · Cited by 227

Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes

Fard, A., Tuck, C. H., Donis, J. A., Sciacca, R. R., Tullio, M. R. D., Wu, H. D., Bryant, T. A., Chen, N.-T., Torres‐Tamayo, M., Ramasamy, R., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.9.2039 · Cited by 221

Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase.

Murray‐Rust, J., LEIPER, J. M., McAlister, M. S. B., Phelan, J. P., Tilley, S. J., MARIA, J. S., Vallance, P. J., & McDonald, N. Q. (2001) · Nature Structural Biology · doi:10.1038/90387 · Cited by 217

Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients

Zoccali, C., Mallamaci, F., Maas, R., Benedetto, F. A., Tripepi, G. L., Malatino, L., Cataliotti, A., Bellanuova, I., Böger, R. H., & on behalf of the CREED INVESTIGATORS (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00437.x · Cited by 213

Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke

Yoo, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00444-0 · Cited by 210

Asymmetric Dimethylarginine, Blood Pressure, and Renal Perfusion in Elderly Subjects

Kielstein, J. T., Bode‐Böger, S. M., Frölich, J. C., Ritz, E., Haller, H. G., & Fliser, D. (2003) · Circulation · doi:10.1161/01.cir.0000060496.23144.a7 · Cited by 210

Short-term Oral Administration of l- Arginine Improves Hemodynamics and Exercise Capacity in Patients with Precapillary Pulmonary Hypertension

Nagaya, N., Uematsu, M., Oya, H., Sato, N., Sakamaki, F., Kyotani, S., Ueno, K., Nakanishi, N., Yamagishi, M., & Miyatake, K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.4.2007116 · Cited by 200

Studies on the catabolism of NG-methylarginine, NG, NG-dimethylarginine and NG, NG-dimethylarginine in the rabbit

MCDERMOTT, J. R. (1976) · Biochemical Journal · doi:10.1042/bj1540179 · Cited by 194

Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia

Holden, D. P., Fickling, S. A., Whitley, G. S. J., & Nussey, S. (1998) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(98)70437-5 · Cited by 181

Oral l-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease

Adams, M. R., McCredie, R. J., Jessup, W., Robinson, J. T. C., SULLIVAN, D. R., & Celermajer, D. S. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06044-3 · Cited by 181

Regression or Progression

Candipan, R. C., Wang, B., Buitrago, R., Tsao, P. S., & Cooke, J. P. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.44 · Cited by 180

Short-term Pulmonary Vasodilation With l -Arginine in Pulmonary Hypertension

Mehta, S., Stewart, D. J., Langleben, D., & Levy, R. D. (1995) · Circulation · doi:10.1161/01.cir.92.6.1539 · Cited by 177

Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery.

Weidinger, F. F., McLenachan, J. M., Cybulsky, M. I., Gordon, J. B., Rennke, H. G., Hollenberg, N. K., Fallon, J. T., Ganz, P., & Cooke, J. P. (1990) · Circulation · doi:10.1161/01.cir.81.5.1667 · Cited by 174

Dietary l-Arginine Supplementation Normalizes Platelet Aggregation in Hypercholesterolemic Humans

Wolf, A., Zalpour, C., Theilmeier, G., Wang, B., Ma, A. O., Anderson, B. E., Tsao, P. S., & Cooke, J. P. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00523-8 · Cited by 171

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes

Asagami, T., Abbasi, F., Stuelinger, M., Lamendola, C. A., McLaughlin, T., Cooke, J. P., Reaven, G. M., & Tsao, P. S. (2002) · Metabolism · doi:10.1053/meta.2002.33349 · Cited by 164

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer’s disease

Selley, M. L. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00007-1 · Cited by 159

Plasma Levels of Asymmetrical Dimethyl-l-Arginine in Patients with Congenital Heart Disease and Pulmonary Hypertension

Gorenflo, M., Zheng, C., Werle, E., Fiehn, W., & Ulmer, H. E. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200104000-00016 · Cited by 150

Cytomegalovirus Infection Impairs the Nitric Oxide Synthase Pathway

Weis, M., Kledal, T. N., Lin, K. Y., Panchal, S. N., Gao, S., Valantine, H. A., Mocarski, E. S., & Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000109692.16004.af · Cited by 149

all- trans -Retinoic Acid Increases Nitric Oxide Synthesis by Endothelial Cells

Achan, V., Tran, C. T. L., Arrigoni, F., Whitley, G. S. J., LEIPER, J. M., & Vallance, P. J. (2002) · Circulation Research · doi:10.1161/01.res.0000014450.40853.2b · Cited by 147

Angiotensin converting enzyme inhibition and angiotensin II AT1-receptor blockade reduce the levels of asymmetrical NG, NG-dimethylarginine in human essential hypertension1

Delles, C., Schneider, M. P., John, S., Gekle, M., & Schmieder, R. E. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)02278-1 · Cited by 141

Asymmetric Dimethylarginine Increases Mononuclear Cell Adhesiveness in Hypercholesterolemic Humans

Chan, J. R., Böger, R. H., Bode‐Böger, S. M., Tangphao, O., Tsao, P. S., Blaschke, T. F., & Cooke, J. P. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.4.1040 · Cited by 140

Angiogenesis Is Impaired by Hypercholesterolemia

Jang, J. J., Ho, H. –. V., Kwan, H. H., Fajardo, L. F., & Cooke, J. P. (2000) · Circulation · doi:10.1161/01.cir.102.12.1414 · Cited by 133

Metabolism of Asymmetric Dimethylarginines Is Regulated in the Lung Developmentally and With Pulmonary Hypertension Induced by Hypobaric Hypoxia

Arrigoni, F., Vallance, P. J., Haworth, S. G., & LEIPER, J. M. (2003) · Circulation · doi:10.1161/01.cir.0000051466.00227.13 · Cited by 133

L-arginine attenuates platelet reactivity in hypercholesterolemic rabbits.

Tsao, P. S., Theilmeier, G., Singer, A. H., Leung, L. L. K., & Cooke, J. P. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.10.1529 · Cited by 125

Evidence for Dysregulation of Dimethylarginine Dimethylaminohydrolase I in Chronic Hypoxia–Induced Pulmonary Hypertension

Millatt, L. J., Whitley, G. S. J., Li, D., LEIPER, J. M., Siragy, H. M., Carey, R. M., & Johns, R. A. (2003) · Circulation · doi:10.1161/01.cir.0000089087.25930.ff · Cited by 123

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients

Fleck, C., Janz, A., Schweitzer, F., Karge, E., Schwertfeger, M., & Stein, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780014.x · Cited by 119

Estrogen Stimulates Dimethylarginine Dimethylaminohydrolase Activity and the Metabolism of Asymmetric Dimethylarginine

Holden, D. P., Cartwright, J. E., Nussey, S., & Whitley, G. S. J. (2003) · Circulation · doi:10.1161/01.cir.0000091083.61609.df · Cited by 117

Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina

Walker, H. A., McGing, E., Fisher, I. B., Böger, R. H., Bode‐Böger, S. M., Jackson, G., Ritter, J. M., & Chowienczyk, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01380-8 · Cited by 112

Renin-Angiotensin System is Involved in the Mechanism of Increased Serum Asymmetric Dimethylarginine in Essential Hypertension.

Ito, A., Egashira, K., Narishige, T., Muramatsu, K., & Takeshita, A. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.775 · Cited by 102

Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan‐induced hyperglycaemia

Masuda, H., Goto, M., Tamaoki, S., & Azuma, H. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702298 · Cited by 99

Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study

Saran, R. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg406 · Cited by 92

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis

Kostourou, V., Robinson, S. P., Cartwright, J. E., & Whitley, G. S. J. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600518 · Cited by 90

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women

Teerlink, T., Neele, S. J. M., de Jong, S., Netelenbos, J. C., & Stehouwer, C. D. A. (2003) · Clinical Science · doi:10.1042/cs20020309 · Cited by 61

Endogenous nitric oxide synthase inhibitors and renal perfusion in patients with heart failure

Kielstein, J. T., Bode‐Böger, S. M., Klein, G. G., Graef, S., Haller, H. G., & Fliser, D. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01149.x · Cited by 60

Effect of Hormone Replacement Therapy on Plasma Levels of the Cardiovascular Risk Factor Asymmetric Dimethylarginine: A Randomized, Placebo-Controlled 12-Week Study in Healthy Early Postmenopausal Women

Post, M. S., Verhoeven, M. O., van der Mooren, M. J., Kenemans, P., Stehouwer, C. D. A., & Teerlink, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030584 · Cited by 58

Heat shock protein 90 and tyrosine kinase regulate eNOS NO· generation but not NO· bioactivity

Ou, J., Fontana, J. T., Ou, Z., Jones, D. W., Ackerman, A. W., Oldham, K. T., Yu, J., Sessa, W. C., & Pritchard, K. A. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00736.2003 · Cited by 53

Effect of local delivery of l-arginine on in-stent restenosis in humans

Suzuki, T., Hayase, M., Hibi, K., Hosokawa, H., Yokoya, K., Fitzgerald, P. J., Yock, P. G., Cooke, J. P., Suzuki, T., & Yeung, A. C. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02252-4 · Cited by 32

Endogenous Nitric Oxide Synthase Inhibitors in Endothelial Cells, Endothelin-1 Within the Vessel Wall, and Intimal Hyperplasia in Perimenopausal Human Uterine Arteries

Beppu, M., Obayashi, S., Asô, T., Goto, M., & Azuma, H. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200202000-00005 · Cited by 27

Plasma concentration of asymmetric dimethylarginine and the risk of coronary heart disease: rationale and design of the multicenter CARDIAC study

Mügge, A., Hanefeld, C., & Böger, R. H. (2003) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(03)00031-x · Cited by 17

Chronic Kidney Disease: Effects on the Cardiovascular System

Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448

Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked?

Rehman, K., & Akash, M. S. H. (2016) · Journal of Biomedical Science · doi:10.1186/s12929-016-0303-y · Cited by 702

Pharmacokinetic and pharmacodynamic properties of oral L‐citrulline and L‐arginine: impact on nitric oxide metabolism

Schwedhelm, E., Maas, R., Freese, R., Jung, D., Lukacs, Z., Jambrecina, A., Spickler, W., Schulze, F., & Böger, R. H. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02990.x · Cited by 494

Nitric oxide and atherosclerosis: An update

Claudio Napoli, A., de Nigris, F., Williams‐Ignarro, S., Pignalosa, O., Sica, V., & Ignarro, L. J. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.03.011 · Cited by 471

Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses

Fernández-Macías, J. C., Ochoa-Martínez, A. C., Varela-Silva, J. A., & Pérez-Maldonado, I. N. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.08.009 · Cited by 458

Asymmetric Dimethylarginine and Atherosclerosis

Qin, J. (2003) · Advances in Cardiovascular Diseases

Asymmetric Dimethylarginine and Cerebrovascular Disorders in Humans

Tsuda, K. (2006) · Stroke · doi:10.1161/01.str.0000248209.76578.3a

Original Article Handling of asymmetrical dimethylarginine and symmetrical

Nijveldt, R. J., Teerlink, T., Guldener, C. V., Prins, H. A., van Lambalgen, A. A., Stehouwer, C. D. A., Rauwerda, J. A., & van Leeuwen, P. A. M. (2015)

Do Homoarginine and Asymmetric Dimethylarginine Act Antagonistically in the Cardiovascular System?

Tsikas, D., & Kayacelebi, A. A. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0484 · Cited by 35

Abstract 4054: Determinants of Circulating Asymmetric Dimethylarginine, Monomethylarginine and L-Arginine: A Population-Based Study

Chirinos, J. A., Lezama, J. M., David, R., Bralley, J. A., Vargas, O. L. M., Zea-Díaz, H., Bolaños, J., Valdivia-Ascuña, Z., Diaz, S. P., Medina, F. F. C., et al. (2006) · Circulation